The 2026 Echo in Pediatric and Congenital Heart Disease Virtual Experience is a two-day virtual course, presented by course directors Jennifer Acevedo ACS, RDCS, FASE and Tam Doan MD, RDCS, FASE, on the latest information on established and emerging cardiovascular ultrasound technologies, clinical care and practical considerations in children and adults with congenital heart disease. Expert physician and sonographer faculty discuss current technologies with a particular focus on how they can be effectively applied in the clinical setting.  

The 2026 Echo in Pediatric and Congenital Heart Disease Virtual Experience is a two-day virtual course, presented by course directors Jennifer Acevedo ACS, RDCS, FASE and Tam Doan MD, RDCS, FASE, on the latest information on established and emerging cardiovascular ultrasound technologies, clinical care and practical considerations in children and adults with congenital heart disease. Expert physician and sonographer faculty discuss current technologies with a particular focus on how they can be effectively applied in the clinical setting.  

Topics include:

Saturday 11/14

Foundations of Pediatric Echocardiography: Imaging Technique and Optimization

This session focuses on the core principles of high-quality pediatric echocardiographic imaging. Participants will review essential image optimization techniques and view-specific acquisition strategies.

Faculty will demonstrate techniques to achieve on-axis alignment, chamber-focused imaging for accurate and reproducible quantification, and comprehensive interrogation of standard and alternative acoustic windows. Emphasis will be placed on recognition of normal anatomic variants and key technical considerations unique to pediatric imaging.

Attendees will gain practical strategies to enhance scanning technique, improve measurement accuracy, and establish a strong technical and conceptual foundation that supports more advanced imaging applications throughout the course.

Advanced Functional Imaging in Congenital Heart Disease: Strain, Diastology, and Ventricular Performance

This session explores advanced functional imaging tools in congenital heart disease, with emphasis on diastolic function, atrial strain, ventricular strain, and single ventricle assessment. Through case-based integration and guideline-driven discussion, participants will learn how to acquire, interpret, and apply strain and diastolic parameters in daily practice.

Faculty will highlight practical acquisition techniques, vendor-related considerations, and common sources of error, while emphasizing how quantitative imaging informs clinical management and longitudinal surveillance.

Lifespan Series I: D-Transposition of the Great Arteries Across the Lifespan

This lifespan-focused session provides a comprehensive imaging roadmap for D-transposition of the great arteries (D-TGA), from fetal diagnosis through adult congenital surveillance. Faculty will highlight stage-specific imaging priorities, surgical considerations, and long-term complications following atrial and arterial switch procedures.

Participants will gain a structured framework for evaluating D-TGA patients at every stage of life and understand when multimodality imaging escalation is warranted.

Sunday 11/15

Torture the Experts! Interactive Fetal Echocardiography Challenge

This highly interactive session challenges expert panelists with complex fetal echocardiography cases. Participants will engage in real-time interpretation, differential diagnosis, and management discussions designed to sharpen pattern recognition and clinical reasoning.

The session emphasizes systematic fetal imaging, diagnostic precision, and practical decision-making under uncertainty.

Imaging After Congenital Heart Defect Repair: Surgical and Transcatheter Surveillance Strategies

This session focuses on imaging surveillance following surgical and transcatheter interventions in congenital heart disease. Faculty will review pre-procedural imaging considerations, procedural guidance, and structured post-repair follow-up strategies.

Participants will learn to recognize expected postoperative findings, identify early and late complications, and determine when advanced imaging is necessary.

Lifespan Series II: Tetralogy of Fallot Across the Lifespan

This session presents a comprehensive imaging approach to Tetralogy of Fallot (TOF) across the lifespan, from fetal diagnosis to adult congenital management. Faculty will address risk stratification, surgical repair variations, right ventricular remodeling, pulmonary regurgitation, conduit dysfunction, and timing of pulmonary valve replacement.

Participants will gain a structured surveillance framework and understand how multimodality imaging integrates into long-term management.

Learning Objectives: 

• Gain practical strategies to enhance scanning technique, improve measurement accuracy, and establish a strong technical and conceptual foundation that supports more advanced imaging applications.
• Understand practical acquisition techniques, vendor-related considerations, and common sources of error.
• Learn a structured framework for evaluating D-TGA patients at every stage of life and understand when multimodality imaging escalation is warranted.
• Review systematic fetal imaging, diagnostic precision, and practical decision-making under uncertainty.
• Learn to recognize expected postoperative findings, identify early and late complications, and determine when advanced imaging is necessary.
• Understand how multimodality imaging integrates into long-term management.

CME Information

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 11.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Registration includes a maximum of 11.00 CME/MOC credits for attending the live virtual course. Attendees will have access to OnDemand content for 90 days from November 23rd, 2026 to February 21st, 2027.

Disclosures:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

• TBA

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• TBA

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

• Contact:
  ASE Learning Hub